CRL Charles River Laboratories International Inc.

Charles River Laboratories Schedules First-Quarter 2024 Earnings Release and Conference Call

WILMINGTON, Mass.--(BUSINESS WIRE)--

Charles River Laboratories International, Inc. (NYSE: CRL) will release first-quarter 2024 financial results on Thursday, May 9th, before the market opens. A conference call has been scheduled to discuss this information on Thursday, May 9th, at 8:30 a.m. ET.

Investors will have the opportunity to listen to a live webcast of the conference call through the Investor Relations section of the Company's website at . A replay will be accessible through the same website.

About Charles River

Charles River provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the globe accelerate their research and drug development efforts. Our dedicated employees are focused on providing clients with exactly what they need to improve and expedite the discovery, early-stage development and safe manufacture of new therapies for the patients who need them. To learn more about our unique portfolio and breadth of services, visit .

EN
12/04/2024

Underlying

CRLCharles River Laboratories International Inc.

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Charles River Laboratories International Inc.

EUR 234.60
CRL Charles River L...

Charles River Laboratories Int'l, Inc.: Update to credit analysis foll...

Charles River credit profile reflects its modest financial leverage and strong free cash flows, offset by its sensitivity to R&D budgets of clients and research funding availability.

CRL CHARLES RIVER LABORATORIES INTERNATIONAL INC.
04/30/24 April 30, 2024 1 EN
EUR 168.91
CRL Charles River L...

Moody's Ratings affirms Charles River's Ba1 CFR, outlook stable

Moody's Ratings (Moody's) affirmed the ratings of Charles River Laboratories International Inc. ("Charles River"). The affirmed ratings include the Ba1 Corporate Family Rating, the Ba1-PD Probability of Default Rating, as well as the Baa3 senior secured ratings, and the Ba2 senior unsecured ratings....

CRL CHARLES RIVER LABORATORIES INTERNATIONAL INC.
04/29/24 April 29, 2024 1 EN
 PRESS RELEASE
Free
CRL Charles River L...

Charles River Laboratories Achieves 100% Renewable Electricity Usage G...

WILMINGTON, Mass.--(BUSINESS WIRE)-- Charles River Laboratories International, Inc. (NYSE: CRL) today announced it has reached 100 percent renewable electricity across all of its global sites as of the first quarter of 2024, significantly ahead of the original target date. In 2020, Charles River became one of the first 300 members of , a global corporate renewable energy initiative, and committed to operating on 100 percent renewable electricity globally by 2030. Today, Charles River joins a small group of leading companies that have achieved this goal organization-wide in accordance with RE10...

April 22, 2024 1 EN
 PRESS RELEASE
Free
CRL Charles River L...

Charles River Laboratories Launches Alternative Methods Advancement Pr...

WILMINGTON, Mass.--(BUSINESS WIRE)-- Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it is launching its Alternative Methods Advancement Project (AMAP), an initiative dedicated to developing alternatives to reduce animal testing. The initiative aims to drive the new standard for drug discovery and development and encapsulates the Company’s initial $200 million investment over the past four years and its five-year goal of investing an additional $300 million. This investment spans a portfolio of technology innovations, partnerships, and advocacy efforts to reduce...

April 16, 2024 1 EN
 PRESS RELEASE
Free
CRL Charles River L...

Charles River Laboratories Schedules First-Quarter 2024 Earnings Relea...

WILMINGTON, Mass.--(BUSINESS WIRE)-- Charles River Laboratories International, Inc. (NYSE: CRL) will release first-quarter 2024 financial results on Thursday, May 9th, before the market opens. A conference call has been scheduled to discuss this information on Thursday, May 9th, at 8:30 a.m. ET. Investors will have the opportunity to listen to a live webcast of the conference call through the Investor Relations section of the Company's website at . A replay will be accessible through the same website. About Charles River Charles River provides essential products and services to help pharma...

April 12, 2024 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch